Publication | Closed Access
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma
92
Citations
19
References
2003
Year
Temozolomide at the dose schedule employed in the current study was tolerated well and had modest activity against previously treated unresectable or metastatic leiomyosarcoma of both uterine and nonuterine origin.
| Year | Citations | |
|---|---|---|
Page 1
Page 1